These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1933826)
1. Effect of recombinant human IL-3 on the mitotic index and karyotype of hemopoietic cells. Kerim S; Rege-Cambrin G; Scaravaglio P; Carozzi F; Saglio G; Aglietta M Cancer Genet Cytogenet; 1991 Sep; 55(2):235-41. PubMed ID: 1933826 [TBL] [Abstract][Full Text] [Related]
2. Relapse and cytogenetic evolution in myeloid neoplasms. Ertz-Archambault N; Kelemen K Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: cytologic and cytogenetic evidence in thirty-four patients. Cuneo A; Balsamo R; Roberti MG; Bardi A; Piva N; Balboni M; Bigoni R; Rigolin GM; Castoldi G Cancer Genet Cytogenet; 1996 Sep; 90(2):171-5. PubMed ID: 8830729 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of proliferation of human myeloid leukemia cells in culture: applications for cytogenetic analysis. Michaeli J; Lerer I; Rachmilewitz EA; Fibach E Blood; 1986 Sep; 68(3):790-3. PubMed ID: 3461854 [TBL] [Abstract][Full Text] [Related]
6. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes]. Bock O Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms. So CC; Ma ES; Wan TS; Yip SF; Chan LC Leuk Res; 2008 Jun; 32(6):1000-1. PubMed ID: 17980911 [No Abstract] [Full Text] [Related]
8. G-CSF for chromosome analysis of myeloid leukemias and MDS. Tsuchiya H; Higuchi S; Asou N; Yamaguchi K; Matsuda I; Yokoyama Y; Murakami T; Kaneko Y Cancer Genet Cytogenet; 1990 Jul; 47(2):277-9. PubMed ID: 1694102 [No Abstract] [Full Text] [Related]
9. [Cytogenetic examination of bone marrow cells in stem cell diseases of myelodysplastic syndromes]. Werner M; Maschek HJ; Kaloutsi V; Buhr T; Kausche F; Delventhal S; Georgii A Verh Dtsch Ges Pathol; 1990; 74():139-43. PubMed ID: 1708572 [TBL] [Abstract][Full Text] [Related]
10. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression. Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343 [TBL] [Abstract][Full Text] [Related]
11. [Importance of GM-CSF for in vitro cytogenetic bone marrow analysis in patients with myelodysplastic syndrome]. Karásková J; Holena O; Michalová K Cas Lek Cesk; 1997 Oct; 136(20):633-7. PubMed ID: 9490208 [TBL] [Abstract][Full Text] [Related]
12. Cytogenetics of chronic myeloproliferative disorders and related myelodysplastic syndromes. Adeyinka A; Dewald GW Hematol Oncol Clin North Am; 2003 Oct; 17(5):1129-49. PubMed ID: 14560778 [TBL] [Abstract][Full Text] [Related]
13. [From conventional cytogenetics to microarrays. Fifty years of Philadelphia chromosome]. Hernández JM; Granada I; Solé F; Med Clin (Barc); 2011 Jul; 137(5):221-9. PubMed ID: 20591449 [TBL] [Abstract][Full Text] [Related]
14. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes. Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250 [TBL] [Abstract][Full Text] [Related]
15. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha. Wetzler M; Estrov Z; Talpaz M; Kim KJ; Alphonso M; Srinivasan R; Kurzrock R Cancer Res; 1994 Apr; 54(7):1837-42. PubMed ID: 8137298 [TBL] [Abstract][Full Text] [Related]
16. Molecular evidence that childhood monosomy 7 syndrome is distinct from juvenile chronic myelogenous leukemia and other childhood myeloproliferative disorders. Butcher M; Frenck R; Emperor J; Paderanga D; Maybee D; Olson K; Shannon K Genes Chromosomes Cancer; 1995 Jan; 12(1):50-7. PubMed ID: 7534111 [TBL] [Abstract][Full Text] [Related]
17. Response of myelodysplastic syndrome marrow progenitor cells to stimualtion with cytokine combinations in a stroma-free long-term culture system. Soligo DA; Campiglio S; Servida F; Bossolasco P; Romitti L; Cortelezzi A; Lambertenghi Deliliers G Br J Haematol; 1996 Mar; 92(3):548-58. PubMed ID: 8616015 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation. Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418 [TBL] [Abstract][Full Text] [Related]
19. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia. Farhi DC; Luckey CN; Siddiqui AM Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936 [TBL] [Abstract][Full Text] [Related]
20. The effect of long-term marrow culture on the nonadherent Philadelphia chromosome-positive clone in chronic myelogenous leukemia: preliminary observations. O'Brien S; Kantarjian HM; Talpaz M; Cork A; Trujillo J; Beran M Hematol Pathol; 1987; 1(3):167-72. PubMed ID: 3509052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]